Search results for " ovary"

showing 10 items of 206 documents

The endocrine pattern of late onset adrenal hyperplasia (21-hydroxylase deficiency)

1984

We describe 5 adult women with severe hirsutism due to late onset 21-hydroxylase deficiency. Diagnosis was performed on the finding of high serum 17-hydroxyprogesterone (17OHP) levels with a marked hyperresponse to an ACTH test. The endocrine study showed in most patients a gonadotropin behavior similar to that observed in classical polycystic ovary (PCO) syndrome. Prolactin levels were slightly increased in basal conditions and presented an exaggerated response to TRH stimulation.

AdultHirsutismendocrine systemmedicine.medical_specialtyAdolescentmedicine.drug_classEndocrinology Diabetes and MetabolismLate onsetEndocrinologyAdrenocorticotropic HormoneInternal medicineHydroxyprogesteronesmedicineHumansEndocrine systemGonadal Steroid HormoneshirsutismAdrenal Hyperplasia Congenitalbiologybusiness.industry17-alpha-HydroxyprogesteroneVirilization21-HydroxylaseLuteinizing Hormonemedicine.diseasePolycystic ovaryProlactinProlactinEndocrinologySteroid Hydroxylasesbiology.proteinFemaleSteroid 21-HydroxylaseFollicle Stimulating Hormonemedicine.symptomGonadotropinbusinesshormones hormone substitutes and hormone antagonistsJournal of Endocrinological Investigation
researchProduct

The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome

2007

BACKGROUND: Insulin glargine is a once-daily basal insulin analog with prolonged duration of action and absence of an evident peak. Glargine is associated with reduced frequency of hypoglycemic episodes (mostly nocturnal) as well as effective glycemic control. Maintenance of good metabolic control before conception and throughout pregnancy is essential to lower the risk of fetal malformations. Glargine might be a valuable alternative in the management of pregnancies complicated by diabetes mellitus. However, because its clinical utility has not been established, the use of glargine is not currently recommended during pregnancy. OBJECTIVE: The aim of this study was to retrospectively evaluat…

AdultHirsutismmedicine.medical_specialtyAdolescentendocrine system diseasesEndocrinology Diabetes and Metabolismmedicine.medical_treatmentModels BiologicalSensitivity and SpecificitySettore MED/13 - EndocrinologiaYoung Adultchemistry.chemical_compoundEndocrinologyInternal medicineAcne VulgarismedicineHumansOutpatient clinicpcos insulin sensitivityRetrospective StudiesMetabolic SyndromeC-peptidebusiness.industryInsulinHyperandrogenismCase-control studynutritional and metabolic diseasesRetrospective cohort studymedicine.diseasePolycystic ovaryfemale genital diseases and pregnancy complicationsOligomenorrheaEndocrinologychemistryCase-Control StudiesFemaleInsulin ResistanceMetabolic syndromeHyperandrogenismbusinessPolycystic Ovary SyndromeClinical Endocrinology
researchProduct

High prevalence of polycystic ovary syndrome in women with mild hirsutism and no other significant clinical symptoms

2010

Objective To verify the conclusions of the Endocrine Society Guidelines that patients with mild hirsutism and no other important clinical signs (menstrual irregularities, infertility, central obesity, acanthosis nigricans, rapid progression of the hirsutism, clitoromegaly) should not be further studied. Design Retrospective study in patients referred because of mild hirsutism and no other clinical signs. Setting Department of Clinical Medicine of the University of Palermo. Patient(s) One hundred fifty-two patients with mild hirsutism. Intervention(s) Measurement of serum testosterone, dehydroepiandrosterone sulfate, 17-OH-Progesterone, assessment of ovulation by measurement of progesterone …

AdultInfertilityHirsutismmedicine.medical_specialtyPediatricsSettore MED/09 - Medicina Internaendocrine system diseasesmedia_common.quotation_subjectClitoromegalyYoung Adultchemistry.chemical_compoundDehydroepiandrosterone sulfatePrevalenceHumansMedicineOvulationAcanthosis nigricanshirsutismRetrospective Studiesmedia_commonGynecologybusiness.industry17-alpha-HydroxyprogesteroneHyperandrogenismObstetrics and Gynecologymedicine.diseasePolycystic ovaryfemale genital diseases and pregnancy complicationsReproductive Medicinechemistrypolycystic ovary syndromeFemalemedicine.symptombusiness
researchProduct

Endometrial gene expression in the window of implantation is altered in obese women especially in association with polycystic ovary syndrome

2010

Objective To determine whether luteal phase endometrial transcriptome is altered in obese women during the window of implantation (WOI), considering the presence of infertility, fat distribution and association with polycystic ovary syndrome (PCOS). Design Prospective study. Setting University-affiliated infertility clinic, between May 2007 and March 2009. Patient(s) One control group of women with normal weight (n = 4), and four study groups of obese women (n = 6 each one) according to the association with infertility, PCOS, and ovarian stimulation. Intervention(s) The endometrium was biopsied 7 days after LH surge or hCG administration in 28 women. Main Outcome Measure(s) Endometrial gene…

AdultInfertilitymedicine.medical_specialtyTime FactorsAdolescentMicroarrayBiopsyLuteal PhaseLuteal phasePeptide receptor activityBiologyEndometriumEndometriumYoung AdultOvulation InductionInternal medicinemedicineCluster AnalysisHumansEmbryo ImplantationObesityProspective StudiesOligonucleotide Array Sequence AnalysisUnexplained infertilityPrincipal Component AnalysisGene Expression ProfilingObstetrics and GynecologyFertility Agents Femalemedicine.diseasePolycystic ovarymedicine.anatomical_structureEndocrinologyGene Expression RegulationReproductive MedicineSpainCase-Control StudiesFemaleTransmembrane transporter activityInfertility FemalePolycystic Ovary SyndromeFertility and Sterility
researchProduct

Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome.

2009

Central fat distribution is increased in anovulatory women with polycystic ovary syndrome (PCOS) compared with ovulatory PCOS and matched controls. Among secreted adipocytokines, this is reflected mainly in lower levels of adiponectin.

AdultLeptinOvulationmedicine.medical_specialtySettore MED/09 - Medicina Internaendocrine system diseasesmedia_common.quotation_subjectAdipokineAdipose tissueBiologyAnovulationInsulin resistanceAdipokinesInternal medicinemedicineBody Fat DistributionHumansNicotinamide PhosphoribosyltransferaseOvulationmedia_commonAdiponectinLeptinnutritional and metabolic diseasesObstetrics and Gynecologymedicine.diseasePolycystic ovaryfat distribution; polycystic ovary syndromeLipidsfemale genital diseases and pregnancy complicationsEndocrinologyC-Reactive ProteinPhenotypeReproductive Medicinefat distributionCase-Control StudiesFemaleAdiponectinInsulin ResistanceWaist CircumferenceRetinol-Binding Proteins PlasmaAnovulationPolycystic Ovary SyndromeFertility and sterility
researchProduct

Evidence for altered adipocyte function in polycystic ovary syndrome.

2005

Background: Adipocytokines are produced by adipose tissue and have been thought to be related to insulin resistance and other health consequences. We measured leptin, adiponectin, and resistin simultaneously in women with polycystic ovary syndrome (PCOS) and age- and weight-matched controls. Our hypothesis was that these simultaneous measurements would help determine whether adipocytokine secretion is abnormal in PCOS independent of body mass and whether these levels are related to insulin resistance as well as other hormonal changes. Methods: Fifty-two women with PCOS and 45 normal ovulatory women who were age- and weight-matched were studied. Blood was obtained for adipocytokines (leptin,…

AdultLeptinmedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and MetabolismAdipose tissueAdipokineBiologyBody Mass Indexchemistry.chemical_compoundresistin polycystic ovary syndromeEndocrinologyInsulin resistanceRETN protein humanInternal medicineAdipocytemedicineIntercellular Signaling Peptides and ProteinAdipocytesHumansResistinAdiponectinLeptinnutritional and metabolic diseasesGeneral Medicinemedicine.diseasePolycystic ovaryleptin; adiponectin; resistin polycystic ovary syndromeEndocrinologychemistryCase-Control StudiesHormones EctopicIntercellular Signaling Peptides and ProteinsResistinFemaleAdiponectinInsulin Resistancehormones hormone substitutes and hormone antagonistsPolycystic Ovary SyndromeEuropean journal of endocrinology
researchProduct

Evidence that insulin and androgens may participate in the regulation of serum leptin levels in women

1999

Abstract Objective: Although serum leptin is principally influenced by body mass, to understand the role of insulin and androgens in the regulation of serum leptin in normal weight women. Design: Prospective observational study. Setting: Academic practice in reproductive endocrinology. Patient(s): Twenty-one women with polycystic ovary syndrome (PCOS) of normal body weight, 8 apparently normal women with polycystic-appearing ovaries (PAO), and 21 normal women. Intervention(s): Fasting blood levels of luteinizing hormone, follicle-stimulating hormone, testosterone (T), unbound T, dehydroepiandrosterone sulfate (DHEAS), insulin, insulin growth factor–binding protein-1 (IGFBP-1), and leptin. M…

AdultLeptinmedicine.medical_specialtymedicine.medical_treatmentBiologychemistry.chemical_compoundFollicle-stimulating hormoneDehydroepiandrosterone sulfateInternal medicinemedicineHumansInsulinTestosteronePancreatic hormoneDehydroepiandrosterone SulfateInsulinLeptinObstetrics and GynecologyLuteinizing HormonePolycystic ovaryEndocrinologyReproductive MedicinechemistryCase-Control StudiesAndrogensFemaleLuteinizing hormonehormones hormone substitutes and hormone antagonistsPolycystic Ovary SyndromeHormoneFertility and Sterility
researchProduct

Androgen excess and cardiovascular risk.

2007

Cardiovascular diseases represent the major cause of death in most of developed countries and ultimately kill as many men as women. Both genders are exposed to the same risk factors but their rates of cardiovascular morbidity and mortality are very different until old age. This represents a crucial point; in fact, only at age 75 and over cardiovascular rates of women approximate those of men. It has been suggested that differences in hormonal status and mainly in androgen levels may explain such gender disparity. Consistently with this hypothesis, it has been shown that women with polycystic ovary syndrome (PCOS) have elevated cardiovascular risk despite their young age. However, the possib…

AdultMaleMiddle AgedCardiovascular DiseasesRisk FactorsCardiovascular DiseasePrevalenceHumansFemaleAdiponectinAge of OnsetInsulin ResistanceHyperandrogenismAgedPolycystic Ovary SyndromeMinerva endocrinologica
researchProduct

Correlates of increased lean muscle mass in women with polycystic ovary syndrome.

2009

ObjectiveMuscle mass plays an important role in determining cardiovascular and metabolic risks in polycystic ovary syndrome (PCOS). In addition, whether lean mass influences carotid intima-media thickness (IMT) in PCOS has not been assessed.DesignProspective investigation.MethodsNinety-five women with PCOS were age- and weight-matched to 90 ovulatory controls. All women had dual X-ray absorptiometry for lean, fat and bone mass, and bone mass density (BMD). Serum testosterone, sex hormone-binding globulin, insulin, and glucose and carotid IMT were determined. Free androgen index (FAI) and insulin resistance (by QUICKI) were calculated.ResultsIn PCOS, waist circumference and insulin were high…

AdultMaleOvulationmedicine.medical_specialtySettore MED/09 - Medicina InternaBone densityAdolescentEndocrinology Diabetes and Metabolismmedicine.medical_treatmentBiologySettore MED/13 - EndocrinologiaBody Mass IndexYoung AdultEndocrinologyWaist–hip ratioInsulin resistanceAbsorptiometry PhotonInternal medicinemedicineHumansInsulinTestosteroneMuscle SkeletalUltrasonographyPCOS Muscle mass Cardiovascular risk atherosclerosis endotheliumFree androgen indexWaist-Hip RatioInsulinBody Weightnutritional and metabolic diseasesGeneral Medicinemedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolarePolycystic ovaryEndocrinologyCarotid ArteriesLean body massAndrogensBody CompositionFemaleSettore M-EDF/01 - Metodi E Didattiche Delle Attivita' MotorieBody mass indexPolycystic Ovary SyndromeEuropean journal of endocrinology
researchProduct

New options in assisted reproduction technology: the Cryotop method of oocyte vitrification

2008

The Cryotop vitrification method has been shown to be a very useful tool for oocyte cryopreservation, giving excellent results regarding survival and clinical outcome. There are several clinical situations in which oocyte cryopreservation provides solutions that have not been available to date. This report describes three of these situations: (i) a low-responder patient who needed a single gene diagnosis due to the presence of a genetic disease; (ii) a patient undergoing endometrial bleeding on the day of oocyte retrieval who was also affected by a genetic disorder; and (iii) a patient who failed to become pregnant after the donation of vitrified oocytes and subsequently had the re-vitrifie…

AdultMaleReproductive Techniques Assistedmedia_common.quotation_subjectSingle geneBiologyPreimplantation genetic diagnosisPolymerase Chain ReactionEmbryo Culture TechniquesAndrologyEndometriumPregnancySurplus embryosEmbryo Culture TechniquemedicineHumansVitrificationPreimplantation Diagnosismedia_commonCryopreservationPregnancy OutcomeObstetrics and GynecologyOocyte cryopreservationOocyteHuntington Diseasemedicine.anatomical_structureReproductive MedicineOocytesFemaleReproductionPolycystic Ovary SyndromeDevelopmental BiologyReproductive BioMedicine Online
researchProduct